This revealed that RUNX1 is an essential epigenetic regulator in both KMT2A-r and KMT2A-w BCP-ALL, which is consistent with previously published data [25,26,27,28,29,30,31,32]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.